
CAS 98902-29-5
:Fórmula:C19H24ClN5O4
InChI:InChI=1S/C19H23N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h4,6,9-11H,5,7-8H2,1-3H3,(H,21,25)(H2,20,22,23);1H
Chave InChI:LYASKMMJFCEPIG-UHFFFAOYSA-N
SMILES:CN(CCCNC(=O)C1=CC=CO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 9 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochlorideFórmula:C19H24ClN5O4Pureza:95%Peso molecular:421.89N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]furan-2-carboxamide Hydrochloride
CAS:Fórmula:C19H23N5O4·ClHCor e Forma:NeatPeso molecular:421.88N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:Fórmula:C19H24ClN5O4Pureza:95%Cor e Forma:SolidPeso molecular:421.87802,3,4,5-Tetradehydro Alfuzosin Hydrochloride
CAS:Impurity Alfuzosin EP Impurity A / Alfuzosin USP Related Compound A
Stability Hygroscopic
Applications 2,3,4,5-Tetradehydro Alfuzosin Hydrochloride (Alfuzosin EP Impurity A) is an impurity of Alfuzosin (A532010) . Alfuzosin (A532010) is an α1-adrenoceptor antagonist with antihypertensive activity.
References Manoury, P.M. et al.: J. Med. Chem., 29, 19 (1986);Fórmula:C19H23N5O4·ClHCor e Forma:NeatPeso molecular:421.88N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochlorideFórmula:C19H24ClN5O4Pureza:95%Peso molecular:421.88N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:Pureza:95%Peso molecular:421.88000492,3,4,5-Tetradehydro alfuzosin hydrochloride
CAS:Alfuzosin is a potent, selective, and long-acting α1A-adrenergic receptor antagonist. It is used to treat benign prostatic hyperplasia (BPH) in males. Alfuzosin is also used as an antihypertensive agent, for the treatment of pheochromocytoma, and for the treatment of benign prostatic hyperplasia in males. The hydrogenation of 2,3,4,5-tetradehydroalfuzosin to alfuzosin hydrochloride is performed by liquid hydrogenation or by hydrogenation on a palladium catalyst in a mixture of dimethylformamide and hexamethylphosphoramide. This process minimizes the formation of impurities such as 2,3,4-trimethoxy alfuzosin.Fórmula:C19H24ClN5O4Pureza:Min. 95%Cor e Forma:White PowderPeso molecular:421.88 g/mol








